Robert A. Hegele

1151 Richmond St,

London, ON, CA

Expertise in

conditions

1151 Richmond St,

London, ON, CA

Overview

Robert Hegele practices in London, Canada. Hegele is highly rated in 36 conditions, according to our data. Their top areas of expertise are Familial Hypertriglyceridemia, High Cholesterol, Apolipoprotein C2 Deficiency, and Familial Lipoprotein Lipase Deficiency.

Their clinical research consists of co-authoring 586 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

1151 Richmond St, London, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia

Enrollment Status: Completed

Publish Date: March 24, 2026

Intervention Type: Drug

Study Drug: ARO-APOC3

Study Phase: Phase 2

A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome

Enrollment Status: Active_not_recruiting

Publish Date: February 04, 2026

Intervention Type: Drug

Study Drug: ARO-APOC3

Study Phase: Phase 3

A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia

Enrollment Status: Completed

Publish Date: December 03, 2025

Intervention Type: Drug

Study Phase: Phase 2

A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)

Enrollment Status: Completed

Publish Date: June 25, 2020

Intervention Type: Drug

Study Phase: Phase 2

View 3 Less Clinical Trials

579 Total Publications

The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome.

Journal: Expert review of endocrinology & metabolism

Published: March 20, 2026

View All 579 Publications

Frequently Asked Questions about Robert A. Hegele

Is Robert A. Hegele a top-rated expert for Familial Hypertriglyceridemia?

MediFind is an objective health platform that identifies experts based on real-world data. Robert A. Hegele is classified as an Elite expert for Familial Hypertriglyceridemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Robert A. Hegele participate in research or clinical trials?

Yes. Robert A. Hegele has published 579 articles and abstracts on conditions like Familial Hypertriglyceridemia. You can view a list of Robert A. Hegele's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hegele's expertise for a condition

ConditionClose